In accordance, it was shown that chemotherapeutic drug doxorubicin activates TGF-β signaling and induces EMT, promoting invasion and generation of cells with stem cell phenotype in murine 4T1 mammary cancer cells [32]. Here, TGFB1 is linked to breast cancer.